Annabidiol Corp.
ACBD · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 12.29 | -0.08 | 133.12 | -14.16 |
| FCF Yield | 0.00% | 0.00% | 0.00% | -0.02% |
| EV / EBITDA | 0.00 | -895.00 | 0.00 | -5,665.32 |
| Quality | ||||
| ROIC | 0.00% | 104.03% | 0.00% | 3.77% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.97 | 2.23 | 4.73 | 3.36 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 22.75% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.13 | 0.00 | 0.22 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |